Mast
Energy Developments PLC
(Incorporated in England and
Wales)
(Registration Number:
12886458)
LEI :213800HFVHGJ9YGO9F71
Share code on the LSE:
MAST
ISIN: GB00BMBSCV12
('MED' or 'the Company')
Dated: 7 August 2024
Mast Energy Developments PLC
('MED' or 'the Company')
Pyebridge Refurbished Genset
Achieves c. £57k Revenue in First Month
Mast Energy Developments PLC,
the UK-based multi-asset owner, developer and operator in the
rapidly growing flexible power market, is pleased to announce an
update regarding its Pyebridge flexible power generation asset
("Pyebridge").
Key
Highlights:
·
First refurbished genset achieves c. £56,689
revenue in first month of operation (inclusive of initial ramp-up
period);
·
Refurbished genset outperforms market with 40%
margin;
·
Resulting in revenue per MW month of c. £21,000;
and
·
Pyebridge site has 3x 2.7MW gensets operation
(thus 8.1MW total), although, to date, only one of which has been
full refurbished and is operating at optimum capacity.
Further to the Company's previous
announcement dated 1 July 2024, following the successful completion
of the refurbishment of the first of the Pyebridge site's 3x 2.7MW
Jenbacher gensets (thus 8.1MW generation capacity in total), the
refurbished genset commenced commercial operational running on 1
July. The MED management team in conjunction with the Pyebridge
site's O&M contractor have carefully monitored the refurbished
genset to ensure optimal performance. An overview of the
refurbished genset's maiden actual performance key data for the
month of July 2024 is provided below, based on the latest available
trading data.
·
Electricity Generation Sales Revenue (via PPA) -
c. £56,689;
·
Total Electricity Generation Output - c. 581
MWh;
·
Average Electricity Generation Sales Price
achieved per MWh sold - c. £98; and
·
Genset Reliability: 100%.
A couple of the key highlights from
July are the achieved revenue per MW month of c. £21,000 and, the
achieved actual average electricity sales price per MWh sold of £98
compared to the average Wholesale Market price of £70 over the same
period, which resulted in a 40% outperformance.
Pyebridge has 3x 2.7MW gensets in
operation (thus 8.1MW total), although, to date, only one of which
has been fully refurbished and is operating at optimum capacity.
Based on the refurbished genset's maiden actual performance data
for the month of July, there is a very clear indication that the
overhaul was indeed successful, which paves the way and underpins
the refurbishment of the Pyebridge site's other two gensets in
sequence, as planned and previously announced.
In addition to the PPA revenue,
Pyebridge is also receiving its current Capacity Market contract's
associated annual gross profit margin income of
c. £308,000 from the government, as previously announced.
It is expected that the Pyebridge site will achieve a gross profit
margin of around 28%.
In order to further bolster
Pyebridge's income streams and profitability, the MED management
team is working on and expects to apply Pyebridge into the
Balancing Mechanism ("BM") market. The BM is used by the
electricity system operator ("ESO") for Great Britain to
procure firm reserve capacity at the day-ahead stage. BM can be
stacked with Capacity Market contracts, with two services from the
same unit during the same time periods, receiving revenue from two
sources for the same MW.
The Project Finance with RiverFort,
as previously announced, has enabled the successful completion of
the first genset's overhaul, and MED is appreciative of RiverFort's
ongoing support as its asset-level strategic funding partner, in
order to grow the business.
To give more insight into the
work-stream involved in overhauling the genset, including photos of
key stages during the process, which has
now been updated following the successful completion of the first
overhaul, please
visit the MED website, "Pyebridge Overhaul Story" webpage at
https://med.energy/?page_id=4466.
MED's other existing sites
In addition to Pyebridge, MED has a
portfolio of other sites that are under development. The following
MED sites, Hindlip (7.5MW), Bordesley (4.5MW)
and Rochdale (4.5MW) are each construction-ready, with
all the requirements for a flexible generation site in place and in
good standing, most notably fully specified EPC and O&M offers,
planning consent, gas connection offer, grid connection offer and
construction management plan. Subject to capex funding, these sites
could immediately continue with their construction phase with an
expected timeline to commercial operations date of around 12 months
from receipt of funding, to go into production and revenue
generation.
Pieter Krügel, MED CEO, commented: "We are very pleased
with the refurbished genset's maiden performance results for the
month of July. The data shows that the overhaul of the first genset
at Pyebridge has indeed been successful, and underpins the overhaul
of the remaining two gensets as planned. Further, the initial data
provides a reasonable indication of Pyebridge's revenue generation
potential.
"MED's funding partnership with RiverFort has enabled and
fast-tracked the work programme at Pyebridge, which will result in
increased revenue generation. RiverFort's ongoing support to MED is
invaluable and much appreciated.
"MED remains committed to growing a portfolio of sites
providing green focused energy generation with a capacity of 100
MW. This growth will be achieved through identified sites and
the acquisition of new sites, similar to
Pyebridge.
"We are looking forward to updating the market with further
progress across the board in due course."
ENDS
This announcement contains inside information for the purposes
of the UK version of the Market Abuse Regulation (EU No. 596/2014)
as it forms part of United Kingdom domestic law by virtue of the
European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the
publication of this announcement, this inside information is now
considered to be in the public domain.
For further information please
visit www.med.energy or contact:
Pieter Krügel
|
info@med.energy
|
Mast Energy
Developments PLC
|
CEO
|
Jon Belliss
|
+44 (0)20 7399 9425
|
Novum Securities
|
Corporate Broker
|